BalasPPagratisN (1981) Experience with Buflomedil in peripheral arterial occlusive disease. Angiology32, 679.
2.
BarnesA JLockePScudderP RDormandyT LDormandyJ ASlackJ (1977) Is hyperviscosity a treatable component of diabetic microcirculatory disease? LancetII, 789.
3.
CalwellJ AHalushkaP VSarjiK EVirellaM F LopesSagelJ (1979) Vascular disease in diabetes. Pathophysiological mechanisms and therapy. Archives of Internal Medicine139, 225.
4.
CloarecM (1976) Traitement des troubles circulatoires périphériques. Etude clinique du LL 1656. Vie Médicale8, 427.
5.
CourtierRBergeronPFouqueR (1981) Double-blind capillaroscopic study of the activity of Buflomedil in Raynaud's Syndrome: a report of 80 cases. Angiology32, 676.
6.
DesandreMCoudrecJ J (1980) Etude clinique du fonzylane dans les artériopathies des membres inférieurs. Angéiologie32, 278.
7.
DitzelJ (1968) Whole-blood viscosity and related components, in diabetes mellitus. Danish Medical Bulletin15, 49.
8.
DormandyJ AErnstE (1981) Effects of Buflomedil on erythrocyte deformability. Angiology32, 714.
9.
FagrellBHermanssonI L (1980) The effect of Buflomedil on skin microcirculation in patients with severe skin ischaemia. European Microcirculation Congress, Garmisch, Germany, September, 1980, abstr. 098.
10.
GalleyPDe BoyssonA (1981) Apport du buflomédil en gériatrie dans le traitement des arterites des membres inférieurs. Revue Gériatrie6, 151.
11.
JuhanIBayleJVaguePJulianC (1978) Déformabilité des hématies chez les diabétiques. Nouvelle Presse Médicale7, 759.
12.
JuhanIBuonocoreMVovanLDurandFCalasM FMoulinJ PVagueP (1979) Filtrabilité des hématies chez les diabétiques. Influence de la glycémie et variations après connection à un pancréas artificie. Nouvelle Presse Médicale8, 4083.
13.
LoweG D OLoweJ MDrummondM MReithSBelchJ J FKessonC MWylieAFouldsW SForbesC DMacCuishA CMandersonW G (1980) Blood viscosity in young male diabetics with and without retinopathy. Diabetologia18, 359.
14.
McMillanD F (1975) Deterioration of the microcirculation in diabetes. Diabetes24, 944.
15.
McMillanD F (1976) Plasma protein changes, blood viscosity and diabetic microangiopathy. Diabetes25, suppl. 2, 858.
MosoraNBaciuTVinczeJ (1972) The viscosity of the serum, haematocrit and fibrinogen in diabetes mellitus and their relationship with diabetes mellitus. Diabetologia8, 59.
18.
OughtonJBarnesA JKohnerE M (1981) Diabetes mellitus: its effect on the flow properties of blood in pathogenic concepts of diabetic microangiopathy. International Workshop Garmish-Grainow. 1980. Thieme-Stratton. p. 112.
19.
Schmid-SchönbeinHVolgerE (1976) Red cell aggregation and red cell deformability in diabetes. Diabetes25, Suppl. 2, 897.
20.
SkovborgFNielsenA VSchlichtkrullJDitzelJ (1966) Blood viscosity in diabetic patients. Lancet1, 129.
21.
TeitelPTietzGOeslenA (1981) Protective effect of Buflomedil on impairment of red blood cell flow behaviour in stress model in vitro. 2nd European Conference of Clinical Haemorheology. London. Abstract p. 90.
22.
TrubesteinGDuongQ D (1981) Comparative evaluation of the effectiveness of Buflomedil and Pentoxifylline in patients with arterial occlusive disease. Angiology32, 705.